International Clinical Trial: Effectiveness and Safety of venovenous ECCO2R (extracorporeal carbon dioxide removal) using a renal replacement therapy device to facilitate lung-protective ventilation in patients with ARDS (acute respiratory distress syndrome) and AKI (acute kidney injury) treated at a tertiary pediatric intensive care unit

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (DRKS00038799) titled 'Effectiveness and Safety of venovenous ECCO2R (extracorporeal carbon dioxide removal) using a renal replacement therapy device to facilitate lung-protective ventilation in patients with ARDS (acute respiratory distress syndrome) and AKI (acute kidney injury) treated at a tertiary pediatric intensive care unit' on April 23.

Study Type: observational

Study Design: Allocation: Masking: Control: Assignment: Study design purpose: other

Primary Sponsor: Klinik f. Allg. Kinder-und Jugendmedizin Freiburg

Condition: Pediatric acute respiratory distress syndrome and acute kidney injury J80.0 N17.0 Acute Respiratory Distre...